Update: GDPR compliance - Klebo/eventflo Conferences
Print Print
Presentation
Wednesday 6 September
DAY 1Auditorium 1Auditorium 2Auditorium 3Auditorium 4ELRIG Tech Theatre - supported by DDWLearning ZoneDAY 1
All times shown are GMT —
DAY 1Auditorium 1Auditorium 2Auditorium 3Auditorium 4ELRIG Tech Theatre - supported by DDWLearning ZoneDAY 1
08:00 Registration Slot
08:00
08:05 08:05
08:10 08:10
08:15 08:15
08:20 08:20
08:25 08:25
08:30 08:30
08:35 08:35
08:40 08:40
08:45 08:45
08:50 08:50
08:55 08:55
09:00 09:00
09:05 09:05
09:10 Slot
Chairs: Catherine Kettleborough, LifeArc, The Accelerator  
09:10
09:15 09:15
09:20 09:20
09:25 09:25
09:30 Slot
Chairs: Katie Chapman, VC funded Biotech Company   Simon Chell, AstraZeneca  Jon Hutchinson, GlaxoSmithKline  Simon Ward, University of Cardiff  
09:30
09:35 Slot
New technologies for the design and characterisation of nanotechnology mediated therapeutics
09:35 (45 mins)
Molly Stevens, Imperial College London  
09:35
09:40 09:40
09:45 09:45
09:50 09:50
09:55 09:55
10:00 10:00
10:05 10:05
10:10 10:10
10:15 10:15
10:20 Refreshment Break Slot
Chairs: Chris Luche, Sanger Institute  Sue Ward, Illumina  
Slot
Chairs: Anne Hammerstein, SPT Labtech  
10:20
10:25 10:25
10:30 10:30
10:35 10:35
10:40 10:40
10:45 10:45
10:50 10:50
10:55 10:55
11:00 11:00
11:05 Slot
Chairs: Sian Lewis, MSD  Michael Howell, The Francis Crick Institute  Session Introduction
11:05 (5 mins)
Sian Lewis, MSD  Michael Howell, The Francis Crick Institute  
High Content Imaging as an enabling tool for early drug discovery
11:10 (30 mins)
John Bassett, MSD  
Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle
11:40 (30 mins)
Rachel Howard-JonesNexcelom from PerkinElmer     
Accelerating Drug Discovery with Cell Painting
12:10 (30 mins)
James Pilling, AstraZeneca  
Microplate readers and imaging systems
12:40 (5 mins)
Imran HaneefLabLogic Systems Limited    
Slot
Chairs: Allan Jordan, Sygnature Discovery  Sarah Skerrat, CHARM Therapeutics  Session Introduction
11:05 (5 mins)
Allan Jordan, Sygnature Discovery  Sarah Skerrat, CHARM Therapeutics  
Discovery and validation of in vitro and in vivo probes for human DNA Polymerase theta (Polθ)
11:10 (30 mins)
Robert Heald, Artios Pharma  
The COVID Moonshot – from open science collaboration in fragment screening to drug candidate and beyond to Pandemic Preparedness
11:40 (30 mins)
Ed Griffen, MedChemica Ltd  
ML/AI:  Opportunities, Impact and Future Directions in Drug Design
12:10 (30 mins)
Sarah Skerrat, CHARM Therapeutics  
Slot
Chairs: Chris Herring, Adaptimmune  Claire Dobson, AstraZeneca  Session Introduction
11:05 (5 mins)
Chris Herring, Adaptimmune  Claire Dobson, AstraZeneca  
TCR Evolution, revolution: How Adaptimmune is developing innovative TCR T-cell therapies to treat solid tumors
11:10 (30 mins)
Jo Brewer, Adaptimmune Limited  
The journey from discovery to therapy begins with a single cell
11:40 (30 mins)
Stephen Hague10x Genomics    
From Stem-Cells to T-Cells: Next-Generation DNA NanoVectors -an Alternative Non-Integrating DNA Vector Platform for Regenerative Medicine and Immunotherapy
12:10 (30 mins)
Richard Harbottle, German Cancer Research Centre (DKFZ)  
Automating high-throughput NGS and qPCR assays: Meet the Biomark™ X and the Juno™
12:40 (5 mins)
James CurtisStandard Bio Tools    
Slot
Chairs: Anna Morgan, Physiology & Pharmacology, Kingston University  Simon Pitchford, King's College London  Session Introduction
11:05 (5 mins)
Anna Morgan, Physiology & Pharmacology, Kingston University  Simon Pitchford, King's College London  
The burden of unmet needs in COPD
11:10 (30 mins)
Wisia Wedzicha, Imperial College London  
Novel drug targets in COPD
11:40 (30 mins)
Ian Adcock, Imperial College London  
New perspectives for modelling inflammatory diseases using patient-derived organoids
12:10 (5 mins)
Sylvia F. BojHUB Organoids    
Use of Imaging for preclinical evaluation of drugs for the treatment of COPD
12:15 (30 mins)
Anna Morgan, Physiology & Pharmacology, Kingston University  
11:05
11:10 11:10
11:15 11:15
11:20 11:20
11:25 11:25
11:30 11:30
11:35 11:35
11:40 11:40
11:45 11:45
11:50 11:50
11:55 11:55
12:00 12:00
12:05 12:05
12:10 12:10
12:15 12:15
12:20 12:20
12:25 12:25
12:30 12:30
12:35 12:35
12:40 12:40
12:45 Refreshment Break - Poster Session 13.15 - 13.45   Slot
Chairs: Yahya Anvar, OKRA.ai  
12:45
12:50 12:50
12:55 12:55
13:00 13:00
13:05 13:05
13:10 13:10
13:15 13:15
13:20 Slot
Chairs: Samantha Kanza, University of Southampton  
13:20
13:25 13:25
13:30 13:30
13:35 13:35
13:40 13:40
13:45 13:45
13:50 13:50
13:55 13:55
14:00 Slot
Phenonaut; a tool for multiomic data integration, analysis, prediction, and inference
14:00 (30 mins)
Steven Shave, University of Edinburgh & GSK  
10x Your Lab: High Content Analysis Meets High-Throughput Screening
14:30 (5 mins)
Kristin HalfpennyAraceli Biosciences    
spheroONE – an automated high throughput spheroid isolation and manipulation technology.
14:35 (5 mins)
Alice CheesbroughCellenion    
Life beyond the pixels: single-cell analysis using deep learning and image analysis methods
14:40 (30 mins)
Peter Horvath, Biological Research Centre, Szeged  
Slot
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery - Design tips and tricks
14:00 (30 mins)
Jamie Scott, AstraZeneca  
Supporting innovations in Splicesome research
14:30 (5 mins)
ROSLYN McConnellAvantor    
New Approaches to the Synthesis and Application of DNA-Encoded Libraries
14:35 (30 mins)
Jessica Graham, Newcastle University  Harriet Stanway-Gordon, Newcastle University  
Slot
Pin-point™ – A Modular Base Editing System Driving Cell and Gene therapies
14:00 (30 mins)
Michael Anbar, Horizon Discovery, a PerkinElmer company  
Assist Plus Pipetting Platform
14:30 (5 mins)
Sharon BarnardINTEGRA Biosciences    
Bioluminescent assay tools for TCR-T and CAR-T development and characterisation
14:35 (5 mins)
Craig MalcolmPromega UK Ltd    
Armouring CAR-T cells therapy against the immunosuppressive microenvironment in solid tumour
14:40 (30 mins)
Romain Lara, AstraZeneca  
Slot
Preclinical translational models for investigating drugs for the treatment of COPD
14:00 (30 mins)
Simon Pitchford, King's College London  
Use of human tissues to investigate drugs for the treatment of COPD
14:30 (30 mins)
Luigino Calzetta, University of Parma   
14:00
14:05 14:05
14:10 14:10
14:15 Slot
Chairs: Paul Avery, BioStrata  
14:15
14:20 14:20
14:25 14:25
14:30 14:30
14:35 14:35
14:40 14:40
14:45 14:45
14:50 14:50
14:55 14:55
15:00 15:00
15:05 15:05
15:10 Refreshment Break 15:10
15:15 Slot
Chairs: Tom Froggatt, Singular Talent  
Slot
Chairs: Zoe Hughes-Thomas, GSK  
15:15
15:20 15:20
15:25 15:25
15:30 15:30
15:35 15:35
15:40 15:40
15:45 Slot
Morphological trajectory inference: Tracking cell state transitions and the impact of small-molecule perturbations
15:45 (30 mins)
Rebecca Hughes, University of Edinburgh  
Magnetic Electrospun Microfibre Scaffold Assemblies: Examples of there use for Cell-Based Screening Applications
16:15 (15 mins)
Gary AllenbyCharnwood Molecular     
Quantitative high-throughput screening of single cancer cell phenotypes in 3D matrices
16:30 (30 mins)
Vicky Bousgouni, Institute of Cancer Research  
Slot
Targeting the template: A novel therapeutic strategy for prion diseases
15:45 (30 mins)
Heulyn Jones, Cardiff University  
Navigate Your Chemistry And Explore The Biology - Case Studies Of CETSA® overcoming challenges in Drug Discovery
16:15 (15 mins)
Isabel Martin CaballeroPelago Bioscience AB    
Audience Lead Panel Discussion with Q&A
16:30 (30 mins)
Allan Jordan, Sygnature Discovery  Sarah Skerrat, CHARM Therapeutics  
Slot
Unlocking a revolutionary class of in vivo reprogramming therapies through systematic, unbiased identification of the key cell switches controlling cell fate
15:45 (30 mins)
Louise Modis, Mogrify  
The impact of not understanding the genetic landscape, Ignorance will cost you time and money.
16:15 (15 mins)
Melanie MaerkenSynthego     
Next Generation Platforms for Human Gene Therapy
16:30 (30 mins)
Aravind Asokan, Duke University   
Slot
Early experimental medicine studies for investigating new drugs for COPD
15:45 (30 mins)
Dave Singh, University of Manchester  
Methods to tackle novel molecular targets involved in inflammatory disease
16:15 (15 mins)
Mark AbbottPeak Proteins Ltd    
Publishing in the British Journal of Pharmacology
16:30 (30 mins)
Charles Whalley, British Pharmacological Society  
15:45
15:50 15:50
15:55 15:55
16:00 16:00
16:05 16:05
16:10 16:10
16:15 16:15
16:20 16:20
16:25 16:25
16:30 16:30
16:35 16:35
16:40 16:40
16:45 16:45
16:50 16:50
16:55 16:55
17:00   17:00
17:05 17:05
17:10 17:10
17:15 Slot
17:15
17:20 17:20
17:25 17:25
17:30 17:30
17:35 17:35
17:40 17:40
17:45 17:45
17:50 17:50
17:55 17:55
18:00 18:00
18:05 18:05
18:10 18:10
18:15 18:15
18:20 18:20
18:25 18:25
18:30 18:30
18:35 18:35
18:40 18:40
18:45 18:45
18:50 18:50
18:55 18:55
19:00   19:00